| << Back |
| XenoPort to Present at the Morgan Stanley Healthcare Conference |
| SANTA CLARA, Calif., Apr 24, 2008 (BUSINESS WIRE) -- XenoPort, Inc. (Nasdaq:XNPT) announced today that it will provide
access via the World Wide Web to its presentation at the Morgan
Stanley Global Healthcare Unplugged Conference. The live presentation
will occur at 12:40 p.m. Pacific Time (3:40 p.m. Eastern Time) on
Thursday, May 1, 2008. A replay of the presentation will also be
available.
To access the live presentation via the Web, please go to www.XenoPort.com. Please connect to the Web site at least 15 minutes prior to the live presentation to ensure adequate time for any software downloads that may be necessary to listen to the Webcast. A replay of the Webcast can be accessed for a minimum of one week and will be available approximately 24 hours after the live presentation. About XenoPort XenoPort, Inc. is a biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the body's natural nutrient transport mechanisms to improve the therapeutic benefits of existing drugs. Its development and commercialization efforts are currently focused on potential treatments of central nervous system disorders. XenoPort's most advanced product candidate, XP13512, has successfully completed three pivotal trials in its Phase 3 clinical program for the treatment of moderate-to-severe primary restless legs syndrome and has successfully completed a Phase 2a clinical trial for the management of post-herpetic neuralgia. XenoPort has also reported positive results from a Phase 2a clinical trial of its second product candidate, XP19986, in patients with gastroesophageal reflux disease. To learn more about XenoPort, please visit the Web site at www.XenoPort.com. XenoPort is a registered U.S. trademark. XNPT2G SOURCE: XenoPort, Inc. XenoPort, Inc. |
| Could not find file '\\us1p-ccsfs01a\Content3\IRXMLDATA\18\187883\Disclaimers.xml'. |